Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcellx (ACLX) Cash & Equivalents (2022 - 2025)

Arcellx has reported Cash & Equivalents over the past 4 years, most recently at $80.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 24.05% year-over-year to $80.3 million; the TTM value through Dec 2025 reached $80.3 million, down 24.05%, while the annual FY2025 figure was $80.3 million, 24.05% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $80.3 million at Arcellx, up from $79.0 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $394.6 million in Q4 2023 and troughed at $62.3 million in Q2 2025.
  • A 4-year average of $152.9 million and a median of $105.7 million in 2024 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: skyrocketed 514.82% in 2023 and later plummeted 73.22% in 2024.
  • Year by year, Cash & Equivalents stood at $64.2 million in 2022, then skyrocketed by 514.82% to $394.6 million in 2023, then plummeted by 73.22% to $105.7 million in 2024, then fell by 24.05% to $80.3 million in 2025.
  • Business Quant data shows Cash & Equivalents for ACLX at $80.3 million in Q4 2025, $79.0 million in Q3 2025, and $62.3 million in Q2 2025.